Skip to main content
SpringerLink
Log in

Physical Activity and Nutrition Optimization in Pancreatic Cancer

  • Chapter
  • First Online:
Pancreatic Cancer

  • 187 Accesses

Abstract

Pancreatic cancer and its treatment may cause muscle loss, weakness, deconditioning, nutritional deficits, and weight loss. Even for patients receiving curative treatment, body weight, body fat, and muscle mass decrease significantly after surgery due to declines in physical activity and challenges in nutritional intake. Fortunately, preoperative nutritional support and preoperative physical activity optimization (prehabilitation) are strategies to minimize muscle loss and rates of malnutrition. Furthermore, early postoperative mobilization and rehabilitation has benefits in oxygenation, physical function, quality of life, and fatigue. Studies have demonstrated the feasibility and safety for exercise for patients with PC; thus, physical activity guidelines should align with those of the American College of Sports Medicine guidelines for cancer survivors, but with individualized tailoring depending on patients’ clinical status and tolerance. Nutritional implications from disease and associated treatments for pancreatic cancer are likely to endure lifelong; thus, support by a clinical dietitian is essential throughout the pancreatic cancer continuum of care.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology—survivorship. 2018;Version 2.2018. 9.

    Google Scholar 

  2. Cormie P, Atkinson M, Bucci L, Cust A, Eakin E, Hayes S, et al. Clinical oncology Society of Australia position statement on exercise in cancer care. Med J Aust. 2018;209(4):184–7.

    Article  PubMed  Google Scholar 

  3. Segal R, Zwaal C, Green E, Tomasone JR, Loblaw A, Petrella T. Exercise for people with cancer: a clinical practice guideline. Curr Oncol. 2017;24(1):40–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Campbell KL, Winters-Stone KM, Wiskemann J, May AM, Schwartz AL, Courneya KS, et al. Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable. Med Sci Sports Exerc. 2019;51(11):2375–90.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Luo H, Galvao DA, Newton RU, Lopez P, Tang C, Fairman CM, et al. Exercise medicine in the management of pancreatic cancer: a systematic review. Pancreas. 2021;50(3):280–92.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Daniels SL, Lee MJ, George J, Kerr K, Moug S, Wilson TR, et al. Prehabilitation in elective abdominal cancer surgery in older patients: systematic review and meta-analysis. BJS Open. 2020;4(6):1022–41.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Ngo-Huang A, Parker NH, Bruera E, Lee RE, Simpson R, O'Connor DP, et al. Home-based exercise Prehabilitation during preoperative treatment for pancreatic cancer is associated with improvement in physical function and quality of life. Integr Cancer Ther. 2019;18:1534735419894061.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Cloyd JM, Hyman S, Huwig T, Monsour C, Santry H, Wills C, et al. Patient experience and quality of life during neoadjuvant therapy for pancreatic cancer: a systematic review and study protocol. Support Care Cancer. 2021;29(6):3009–16.

    Article  PubMed  Google Scholar 

  9. Moriello C, Mayo NE, Feldman L, Carli F. Validating the six-minute walk test as a measure of recovery after elective colon resection surgery. Arch Phys Med Rehabil. 2008;89(6):1083–9.

    Article  PubMed  Google Scholar 

  10. Hayashi K, Yokoyama Y, Nakajima H, Nagino M, Inoue T, Nagaya M, et al. Preoperative 6-minute walk distance accurately predicts postoperative complications after operations for hepato-pancreato-biliary cancer. Surgery. 2017;161(2):525–32.

    Article  PubMed  Google Scholar 

  11. Keeratichananont W, Thanadetsuntorn C, Keeratichananont S. Value of preoperative 6-minute walk test for predicting postoperative pulmonary complications. Ther Adv Respir Dis. 2016;10(1):18–25.

    Article  PubMed  Google Scholar 

  12. Lai Y, Su J, Qiu P, Wang M, Zhou K, Tang Y, et al. Systematic short-term pulmonary rehabilitation before lung cancer lobectomy: a randomized trial. Interact Cardiovasc Thorac Surg. 2017;25(3):476–83.

    Article  PubMed  Google Scholar 

  13. Gillis C, Li C, Lee L, Awasthi R, Augustin B, Gamsa A, et al. Prehabilitation versus rehabilitation: a randomized control trial in patients undergoing colorectal resection for cancer. Anesthesiology. 2014;121(5):937–47.

    Article  PubMed  Google Scholar 

  14. Zhang F, Ferrucci L, Culham E, Metter EJ, Guralnik J, Deshpande N. Performance on five times sit-to-stand task as a predictor of subsequent falls and disability in older persons. J Aging Health. 2013;25(3):478–92.

    Article  PubMed  Google Scholar 

  15. Parker NH, Lee RE, O'Connor DP, Ngo-Huang A, Petzel MQB, Schadler K, et al. Supports and barriers to home-based physical activity during preoperative treatment of pancreatic cancer: a mixed-methods study. J Phys Act Health. 2019;16(12):1113–22.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Hsueh HY, Pita-Grisanti V, Gumpper-Fedus K, Lahooti A, Chavez-Tomar M, Schadler K, et al. A review of physical activity in pancreatic ductal adenocarcinoma: epidemiology, intervention, animal models, and clinical trials. Pancreatology. 2022;22(1):98–111.

    Article  CAS  PubMed  Google Scholar 

  17. Schadler KL, Thomas NJ, Galie PA, Bhang DH, Roby KC, Addai P, et al. Tumor vessel normalization after aerobic exercise enhances chemotherapeutic efficacy. Oncotarget. 2016;7(40):65429–40.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Florez Bedoya CA, Cardoso ACF, Parker N, Ngo-Huang A, Petzel MQ, Kim MP, et al. Exercise during preoperative therapy increases tumor vascularity in pancreatic tumor patients. Sci Rep. 2019;9(1):13966.

    Article  PubMed Central  PubMed  Google Scholar 

  19. Fagevik Olsén M, Becovic S, Dean E. Short-term effects of mobilization on oxygenation in patients after open surgery for pancreatic cancer: a randomized controlled trial. BMC Surg. 2021;21(1):185.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Steindorf K, Clauss D, Tjaden C, Hackert T, Herbolsheimer F, Bruckner T, et al. Quality of life, fatigue, and sleep problems in pancreatic cancer patients—a randomized trial on the effects of exercise. Dtsch Arztebl Int. 2019;116(27–28):471–8.

    PubMed Central  PubMed  Google Scholar 

  21. O'Connor D, Brown M, Eatock M, Turkington RC, Prue G. Exercise efficacy and prescription during treatment for pancreatic ductal adenocarcinoma: a systematic review. BMC Cancer. 2021;21(1):43.

    Article  PubMed Central  PubMed  Google Scholar 

  22. Arthur AE, Delk A, Demark-Wahnefried W, Christein JD, Contreras C, Posey JA 3rd, et al. Pancreatic cancer survivors' preferences, barriers, and facilitators related to physical activity and diet interventions. J Cancer Surviv. 2016;10(6):981–9.

    Article  PubMed Central  PubMed  Google Scholar 

  23. Parker NH, Basen-Engquist K, Rubin ML, Li Y, Prakash L, Ngo-Huang A, et al. Factors influencing exercise following pancreatic tumor resection. Ann Surg Oncol. 2021;28(4):2299–309.

    Article  PubMed  Google Scholar 

  24. Mintziras I, Miligkos M, Wachter S, Manoharan J, Maurer E, Bartsch DK. Sarcopenia and sarcopenic obesity are significantly associated with poorer overall survival in patients with pancreatic cancer: systematic review and meta-analysis. Int J Surg. 2018;59:19–26.

    Article  PubMed  Google Scholar 

  25. Poulia KA, Sarantis P, Antoniadou D, Koustas E, Papadimitropoulou A, Papavassiliou AG, et al. Pancreatic cancer and cachexia-metabolic mechanisms and novel insights. Nutrients. 2020;12(6):1543.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Michaelis KA, Zhu X, Burfeind KG, Krasnow SM, Levasseur PR, Morgan TK, et al. Establishment and characterization of a novel murine model of pancreatic cancer cachexia. J Cachexia Sarcopenia Muscle. 2017;8(5):824–38.

    Article  PubMed Central  PubMed  Google Scholar 

  27. Sandini M, Patino M, Ferrone CR, Alvarez-Perez CA, Honselmann KC, Paiella S, et al. Association between changes in body composition and neoadjuvant treatment for pancreatic cancer. JAMA Surg. 2018;153(9):809–15.

    Article  PubMed Central  PubMed  Google Scholar 

  28. Kurokawa H, Akezaki Y, Tominaga R, Okamoto M, Kikuuchi M, Hamada M, et al. Changes in physical function and effects on QOL in patients after pancreatic cancer surgery. Healthcare (Basel). 2021;9(7):882.

    Article  PubMed  Google Scholar 

  29. Cloyd JM, Nogueras-Gonzalez GM, Prakash LR, Petzel MQB, Parker NH, Ngo-Huang AT, et al. Anthropometric changes in patients with pancreatic cancer undergoing preoperative therapy and Pancreatoduodenectomy. J Gastrointest Surg. 2018;22(4):703–12.

    Article  PubMed  Google Scholar 

  30. Babic A, Rosenthal MH, Bamlet WR, Takahashi N, Sugimoto M, Danai LV, et al. Postdiagnosis loss of skeletal muscle, but not adipose tissue, is associated with shorter survival of patients with advanced pancreatic cancer. Cancer Epidemiol Biomark Prev. 2019;28(12):2062–9.

    Article  CAS  Google Scholar 

  31. Basile D, Corvaja C, Caccialanza R, Aprile G. Sarcopenia: looking to muscle mass to better manage pancreatic cancer patients. Curr Opin Support Palliat Care. 2019;13(4):279–85.

    Article  PubMed  Google Scholar 

  32. Parker NH, Gorzelitz J, Ngo-Huang A, Caan BJ, Prakash L, Garg N, et al. The role of home-based exercise in maintaining skeletal muscle during preoperative pancreatic cancer treatment. Integr Cancer Ther. 2021;20:1534735420986615.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  33. Kamel FH, Basha MA, Alsharidah AS, Salama AB. Resistance training impact on mobility, muscle strength and lean mass in pancreatic cancer cachexia: a randomized controlled trial. Clin Rehabil. 2020;34(11):1391–9.

    Article  PubMed  Google Scholar 

  34. Clifford B, Koizumi S, Wewege MA, Leake HB, Ha L, Macdonald E, et al. The effect of resistance training on body composition during and after cancer treatment: a systematic review and meta-analysis. Sports Med. 2021;51(12):2527–46.

    Article  PubMed  Google Scholar 

  35. Vedie AL, Neuzillet C. Pancreatic cancer: best supportive care. Presse Med. 2019;48(3 Pt 2):e175–e85.

    Article  PubMed  Google Scholar 

  36. Kim E, Kang JS, Han Y, Kim H, Kwon W, Kim JR, et al. Influence of preoperative nutritional status on clinical outcomes after pancreatoduodenectomy. HPB (Oxford). 2018;20(11):1051–61.

    Article  PubMed  Google Scholar 

  37. Vashi P, Popiel B, Lammersfeld C, Gupta D. Outcomes of systematic nutritional assessment and medical nutrition therapy in pancreatic cancer. Pancreas. 2015;44(5):750–5.

    Article  CAS  PubMed  Google Scholar 

  38. Mueller TC, Burmeister MA, Bachmann J, Martignoni ME. Cachexia and pancreatic cancer: are there treatment options? World J Gastroenterol. 2014;20(28):9361–73.

    PubMed Central  PubMed  Google Scholar 

  39. Ottery F. Supportive nutritional management of the patient with pancreatic cancer. Oncology (Williston Park). 1996;10(9 Suppl):26–32.

    CAS  PubMed  Google Scholar 

  40. Bruera E. ABC of palliative care. Anorexia, cachexia, and nutrition. BMJ. 1997;315(7117):1219–22.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  41. Dev R. Measuring cachexia-diagnostic criteria. Ann Palliat Med. 2019;8(1):24–32.

    Article  PubMed  Google Scholar 

  42. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12(5):489–95.

    Article  PubMed  Google Scholar 

  43. Muscaritoli M, Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, et al. ESPEN practical guideline: clinical nutrition in cancer. Clin Nutr. 2021;40(5):2898–913.

    Article  PubMed  Google Scholar 

  44. Hendifar AE, Petzel MQB, Zimmers TA, Denlinger CS, Matrisian LM, Picozzi VJ, et al. Pancreas cancer-associated weight loss. Oncologist. 2018;24:691.

    Article  PubMed Central  PubMed  Google Scholar 

  45. Davidson W, Ash S, Capra S, Bauer J. Weight stabilisation is associated with improved survival duration and quality of life in unresectable pancreatic cancer. Clin Nutr. 2004;23(2):239–47.

    Article  PubMed  Google Scholar 

  46. Kim SH, Lee SM, Jeung HC, Lee IJ, Park JS, Song M, et al. The effect of nutrition intervention with oral nutritional supplements on pancreatic and bile duct cancer patients undergoing chemotherapy. Nutrients. 2019;11(5):1145.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  47. Solheim TS, Laird BJA, Balstad TR, Stene GB, Bye A, Johns N, et al. A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer. J Cachexia Sarcopenia Muscle. 2017;8(5):778–88.

    Article  PubMed Central  PubMed  Google Scholar 

  48. Deutz NE, Bauer JM, Barazzoni R, Biolo G, Boirie Y, Bosy-Westphal A, et al. Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN expert group. Clin Nutr. 2014;33(6):929–36.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  49. Akita H, Takahashi H, Asukai K, Tomokuni A, Wada H, Marukawa S, et al. The utility of nutritional supportive care with an eicosapentaenoic acid (EPA)-enriched nutrition agent during pre-operative chemoradiotherapy for pancreatic cancer: prospective randomized control study. Clin Nutr. 2019;33:148–53.

    Google Scholar 

  50. Cao DX, Wu GH, Zhang B, Quan YJ, Wei J, Jin H, et al. Resting energy expenditure and body composition in patients with newly detected cancer. Clin Nutr. 2010;29(1):72–7.

    Article  PubMed  Google Scholar 

  51. Falconer JS, Fearon KC, Plester CE, Ross JA, Carter DC. Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer. Ann Surg. 1994;219(4):325–31.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  52. Sasaki M, Okamoto H, Johtatsu T, Kurihara M, Iwakawa H, Tanaka T, et al. Resting energy expenditure in patients undergoing pylorus preserving pancreatoduodenectomies for bile duct cancer or pancreatic tumors. J Clin Biochem Nutr. 2011;48(3):183–6.

    Article  PubMed Central  PubMed  Google Scholar 

  53. Cederholm T, Jensen GL, Correia M, Gonzalez MC, Fukushima R, Higashiguchi T, et al. GLIM criteria for the diagnosis of malnutrition—a consensus report from the global clinical nutrition community. J Cachexia Sarcopenia Muscle. 2019;10(1):207–17.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  54. Paddon-Jones D, Rasmussen BB. Dietary protein recommendations and the prevention of sarcopenia. Curr Opin Clin Nutr Metab Care. 2009;12(1):86–90.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  55. DiMagno EP, Reber HA, Tempero MA. AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association Gastroenterology. 1999;117(6):1464–84.

    CAS  PubMed  Google Scholar 

  56. National Cancer Institute. Pancreatic Cancer Treatment (PDQ(R))-Health Professional Version 2020 [updated 5/15/2020]. https://www.cancer.gov/types/pancreatic/hp/pancreatic-treatment-pdq.

  57. Sarner M. Treatment of pancreatic exocrine deficiency. World J Surg. 2003;27(11):1192–5.

    Article  PubMed  Google Scholar 

  58. Poulson J. The management of diabetes in patients with advanced cancer. J Pain Symptom Manag. 1997;13(6):339–46.

    Article  CAS  Google Scholar 

  59. Academy of Nutrition and Dietetics. Gastroparesis. Nutrition Care Manual 2020; https://www.nutritioncaremanual.org/client_ed.cfm?ncm_client_ed_id=168. Accessed 18 May 2020.

  60. Beane JD, House MG, Miller A, et al. Optimal management of delayed gastric emptying after pancreatectomy: an analysis of 1,089 patients. Surgery. 2014;156(4):939–46.

    Article  PubMed  Google Scholar 

  61. Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L. American College of G. clinical guideline: management of gastroparesis. Am J Gastroenterol. 2013;108(1):18–37; quiz 38.

    Article  CAS  PubMed  Google Scholar 

  62. August DA, Huhmann MB, American Society for P, Enteral Nutrition Board of D.A.S.P.E.N. Clinical guidelines: nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation. JPEN J Parenter Enteral Nutr. 2009;33(5):472–500.

    Article  PubMed  Google Scholar 

  63. Koop AH, Palmer WC, Stancampiano FF. Gastric outlet obstruction: a red flag, potentially manageable. Cleve Clin J Med. 2019;86(5):345–53.

    Article  PubMed  Google Scholar 

  64. Oh SY, Edwards A, Mandelson M, et al. Survival and clinical outcome after endoscopic duodenal stent placement for malignant gastric outlet obstruction: comparison of pancreatic cancer and nonpancreatic cancer. Gastrointest Endosc. 2015;82(3):460–468 e462.

    Article  PubMed  Google Scholar 

  65. Orr J, Lockwood R, Gamboa A, Slaughter JC, Obstein KL, Yachimski P. Enteral stents for malignant gastric outlet obstruction: low reintervention rates for obstruction due to pancreatic adenocarcinoma versus other etiologies. J Gastrointest Surg. 2020;25:720.

    Article  PubMed  Google Scholar 

  66. Manuel-Vazquez A, Latorre-Fragua R, Ramiro-Perez C, Lopez-Marcano A, la Plaza-Llamas R, Ramia JM. Laparoscopic gastrojejunostomy for gastric outlet obstruction in patients with unresectable hepatopancreatobiliary cancers: a personal series and systematic review of the literature. World J Gastroenterol. 2018;24(18):1978–88.

    Article  PubMed Central  PubMed  Google Scholar 

  67. Yoshida Y, Fukutomi A, Tanaka M, et al. Gastrojejunostomy versus duodenal stent placement for gastric outlet obstruction in patients with unresectable pancreatic cancer. Pancreatology. 2017;17(6):983–9.

    Article  PubMed  Google Scholar 

  68. Perone JA, Riall TS, Olino K. Palliative care for pancreatic and periampullary cancer. Surg Clin North Am. 2016;96(6):1415–30.

    Article  PubMed Central  PubMed  Google Scholar 

  69. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology Pancreatic Adenocarcinoma Version 1.2020. 2019; https://www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdf. Accessed 18 May 2020.

  70. Adler DG, Baron TH. Endoscopic palliation of malignant gastric outlet obstruction using self-expanding metal stents: experience in 36 patients. Am J Gastroenterol. 2002;97(1):72–8.

    Article  PubMed  Google Scholar 

  71. Dormann A, Meisner S, Verin N, Wenk LA. Self-expanding metal stents for gastroduodenal malignancies: systematic review of their clinical effectiveness. Endoscopy. 2004;36(6):543–50.

    Article  CAS  PubMed  Google Scholar 

  72. Pothuri B, Montemarano M, Gerardi M, et al. Percutaneous endoscopic gastrostomy tube placement in patients with malignant bowel obstruction due to ovarian carcinoma. Gynecol Oncol. 2005;96(2):330–4.

    Article  PubMed  Google Scholar 

  73. Babayan VK. Medium chain triglycerides and structured lipids. Lipids. 1987;22(6):417–20.

    Article  CAS  PubMed  Google Scholar 

  74. White A. Outpatient interventions for hepatology patients with fluid retention: a review and synthesis of the literature. Gastroenterol Nurs. 2014;37(3):236–44.

    Article  PubMed  Google Scholar 

  75. Moore KP, Aithal GP. Guidelines on the management of ascites in cirrhosis. Gut. 2006;55(Suppl 6):vi1-12.

    PubMed  Google Scholar 

  76. Yu AS, Hu KQ. Management of ascites. Clin Liver Dis. 2001;5(2):541–68. viii

    Article  CAS  PubMed  Google Scholar 

  77. National Cancer Institute. Nutrition in cancer care (PDQ(R))- Health professionals. Nutrition in cancer care (PDQ(R))- Health professionals. 2020; https://www.cancer.gov/about-cancer/treatment/side-effects/appetite-loss/nutrition-hp-pdq#_74. Accessed 1 May 2020.

  78. Rabow MW, Petzel MQB, Adkins SH. Symptom management and palliative Care in Pancreatic Cancer. Cancer J. 2017;23(6):362–73.

    Article  PubMed  Google Scholar 

  79. Bisanz A, Tucker AM, Amin DM, et al. Summary of the causative and treatment factors of diarrhea and the use of a diarrhea assessment and treatment tool to improve patient outcomes. Gastroenterol Nurs. 2010;33(4):268–81; quiz 282–263.

    Article  PubMed  Google Scholar 

  80. Murphy J, Stacey D, Crook J, Thompson B, Panetta D. Testing control of radiation-induced diarrhea with a psyllium bulking agent: a pilot study. Can Oncol Nurs J. 2000;10(3):96–100.

    Article  CAS  PubMed  Google Scholar 

  81. Singh B. Psyllium as therapeutic and drug delivery agent. Int J Pharm. 2007;334(1–2):1–14.

    Article  CAS  PubMed  Google Scholar 

  82. Bisanz A, Tucker AM, Amin DM, Patel D, Calderon BB, Joseph MM, et al. Summary of the causative and treatment factors of diarrhea and the use of a diarrhea assessment and treatment tool to improve patient outcomes. Gastroenterol Nurs. 2010;33(4):268–81; quiz 82–3.

    Article  PubMed  Google Scholar 

  83. Cui Y, Andersen DK. Pancreatogenic diabetes: special considerations for management. Pancreatology. 2011;11(3):279–94.

    Article  PubMed  Google Scholar 

  84. Phillips ME. Pancreatic exocrine insufficiency following pancreatic resection. Pancreatology. 2015;15(5):449–55.

    Article  PubMed  Google Scholar 

  85. Sabater L, Ausania F, Bakker OJ, Boadas J, Dominguez-Munoz JE, Falconi M, et al. Evidence-based guidelines for the management of exocrine pancreatic insufficiency after pancreatic surgery. Ann Surg. 2016;264(6):949–58.

    Article  PubMed  Google Scholar 

  86. Dominguez-Munoz JE. Diagnosis and treatment of pancreatic exocrine insufficiency. Curr Opin Gastroenterol. 2018;34(5):349–54.

    Article  PubMed  Google Scholar 

  87. Nikfarjam M, Wilson JS, Smith RC. Australasian pancreatic club pancreatic enzyme replacement therapy guidelines working G. diagnosis and management of pancreatic exocrine insufficiency. Med J Aust. 2017;207(4):161–5.

    Article  PubMed  Google Scholar 

  88. Bartel MJ, Asbun H, Stauffer J, Raimondo M. Pancreatic exocrine insufficiency in pancreatic cancer: a review of the literature. Dig Liver Dis. 2015;47(12):1013–20.

    Article  PubMed  Google Scholar 

  89. Imrie CW, Connett G, Hall RI, Charnley RM. Review article: enzyme supplementation in cystic fibrosis, chronic pancreatitis, pancreatic and periampullary cancer. Aliment Pharmacol Ther. 2010;32(Suppl 1):1–25.

    Article  CAS  PubMed  Google Scholar 

  90. Horst E, Seidel M, Micke O, Rube C, Glashorster M, Schafer U, et al. Accelerated radiochemotherapy in pancreatic cancer is not necessarily related to a pathologic pancreatic function decline in the early period. Int J Radiat Oncol Biol Phys. 2002;52(2):304–9.

    Article  PubMed  Google Scholar 

  91. Capurso G, Traini M, Piciucchi M, Signoretti M, Arcidiacono PG. Exocrine pancreatic insufficiency: prevalence, diagnosis, and management. Clin Exp Gastroenterol. 2019;12:129–39.

    Article  PubMed Central  PubMed  Google Scholar 

  92. Powell-Brett S, de Liguori CN, Roberts K. Understanding pancreatic exocrine insufficiency and replacement therapy in pancreatic cancer. Eur J Surg Oncol. 2021;47(3 Pt A):539–44.

    Article  CAS  PubMed  Google Scholar 

  93. Petzel MQB. Medical nutrition therapy for pancreatic cancer. In: Voss AC, Williams V, editors. Oncology nutrition for clinical practice. 2nd ed. Chicago IL: Academy of Nutrition and Dietetics; 2021. p. 434–71.

    Google Scholar 

  94. Sabater L, Ausania F, Bakker OJ, et al. Evidence-based guidelines for the management of exocrine pancreatic insufficiency after pancreatic surgery. Ann Surg. 2016;264(6):949–58.

    Article  PubMed  Google Scholar 

  95. Bruno MJ, Haverkort EB, Tijssen GP, Tytgat GN, van Leeuwen DJ. Placebo controlled trial of enteric coated pancreatin microsphere treatment in patients with unresectable cancer of the pancreatic head region. Gut. 1998;42(1):92–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  96. Dominguez-Munoz JE, Nieto-Garcia L, Lopez-Diaz J, Larino-Noia J, Abdulkader I, Iglesias-Garcia J. Impact of the treatment of pancreatic exocrine insufficiency on survival of patients with unresectable pancreatic cancer: a retrospective analysis. BMC Cancer. 2018;18(1):534.

    Article  PubMed Central  PubMed  Google Scholar 

  97. Roberts KJ, Bannister CA, Schrem H. Enzyme replacement improves survival among patients with pancreatic cancer: results of a population based study. Pancreatology. 2019;19(1):114–21.

    Article  CAS  PubMed  Google Scholar 

  98. Roberts KJ, Schrem H, Hodson J, Angelico R, Dasari BVM, Coldham CA, et al. Pancreas exocrine replacement therapy is associated with increased survival following pancreatoduodenectomy for periampullary malignancy. HPB (Oxford). 2017;19(10):859–67.

    Article  PubMed  Google Scholar 

  99. Gooden HM, White KJ. Pancreatic cancer and supportive care—pancreatic exocrine insufficiency negatively impacts on quality of life. Support Care Cancer. 2013;21(7):1835–41.

    Article  CAS  PubMed  Google Scholar 

  100. Landers A, Muircroft W, Brown H. Pancreatic enzyme replacement therapy (PERT) for malabsorption in patients with metastatic pancreatic cancer. BMJ Support Palliat Care. 2016;6(1):75–9.

    Article  PubMed  Google Scholar 

  101. Fieker A, Philpott J, Armand M. Enzyme replacement therapy for pancreatic insufficiency: present and future. Clin Exp Gastroenterol. 2011;4:55–73.

    PubMed Central  PubMed  Google Scholar 

  102. Layer P, Keller J, Lankisch PG. Pancreatic enzyme replacement therapy. Curr Gastroenterol Rep. 2001;3(2):101–8.

    Article  CAS  PubMed  Google Scholar 

  103. Ellison NM, Chevlen E, Still CD, Dubagunta S. Supportive care for patients with pancreatic adenocarcinoma: symptom control and nutrition. Hematol Oncol Clin North Am. 2002;16(1):105–21.

    Article  PubMed  Google Scholar 

  104. Petzel MQB, Hoffman L. Nutrition implications for long-term survivors of pancreatic cancer surgery [formula: see text]. Nutr Clin Pract. 2017;32(5):588–98.

    Article  PubMed  Google Scholar 

  105. Struyvenberg MR, Martin CR, Freedman SD. Practical guide to exocrine pancreatic insufficiency—breaking the myths. BMC Med. 2017;15(1):29.

    Article  PubMed Central  PubMed  Google Scholar 

  106. Creon R. Package insert. North Chicago, IL: AbbVie Inc.; 2015.

    Google Scholar 

  107. Toouli J, Biankin AV, Oliver MR, Pearce CB, Wilson JS, Wray NH, et al. Management of pancreatic exocrine insufficiency: Australasian pancreatic Club recommendations. Med J Aust. 2010;193(8):461–7.

    Article  PubMed  Google Scholar 

  108. Edakkanambeth Varayil J, Bauer BA, Hurt RT. Over-the-counter enzyme supplements: what a clinician needs to know. Mayo Clin Proc. 2014;89(9):1307–12.

    Article  CAS  PubMed  Google Scholar 

  109. Tsukagoshi M, Harimoto N, Araki K, Kubo N, Watanabe A, Igarashi T, et al. Impact of preoperative nutritional support and rehabilitation therapy in patients undergoing pancreaticoduodenectomy. Int J Clin Oncol. 2021;26(9):1698–706.

    Article  CAS  PubMed  Google Scholar 

  110. Burden S, Todd C, Hill J, Lal S. Pre-operative nutrition support in patients undergoing gastrointestinal surgery. Cochrane Database Syst Rev. 2012;11:CD008879.

    PubMed  Google Scholar 

  111. Martin RC 2nd, Agle S, Schlegel M, Hayat T, Scoggins CR, McMasters KM, et al. Efficacy of preoperative immunonutrition in locally advanced pancreatic cancer undergoing irreversible electroporation (IRE). Eur J Surg Oncol. 2017;43(4):772–9.

    Article  PubMed  Google Scholar 

  112. Silvestri S, Franchello A, Deiro G, Galletti R, Cassine D, Campra D, et al. Preoperative oral immunonutrition versus standard preoperative oral diet in well nourished patients undergoing pancreaticoduodenectomy. Int J Surg. 2016;31:93–9.

    Article  CAS  PubMed  Google Scholar 

  113. Gade J, Levring T, Hillingso J, Hansen CP, Andersen JR. The effect of preoperative oral immunonutrition on complications and length of hospital stay after elective surgery for pancreatic cancer—a randomized controlled trial. Nutr Cancer. 2016;68(2):225–33.

    Article  PubMed  Google Scholar 

  114. Shirakawa H, Kinoshita T, Gotohda N, Takahashi S, Nakagohri T, Konishi M. Compliance with and effects of preoperative immunonutrition in patients undergoing pancreaticoduodenectomy. J Hepatobiliary Pancreat Sci. 2012;19(3):249–58.

    Article  PubMed  Google Scholar 

  115. Suzuki D, Furukawa K, Kimura F, Shimizu H, Yoshidome H, Ohtsuka M, et al. Effects of perioperative immunonutrition on cell-mediated immunity, T helper type 1 (Th1)/Th2 differentiation, and Th17 response after pancreaticoduodenectomy. Surgery. 2010;148(3):573–81.

    Article  PubMed  Google Scholar 

  116. Gilliland TM, Villafane-Ferriol N, Shah KP, Shah RM, Tran Cao HS, Massarweh NN, et al. Nutritional and metabolic derangements in pancreatic cancer and pancreatic resection. Nutrients. 2017;9(3):243.

    Article  PubMed Central  PubMed  Google Scholar 

  117. Adiamah A, Skorepa P, Weimann A, Lobo DN. The impact of preoperative immune modulating nutrition on outcomes in patients undergoing surgery for gastrointestinal cancer: a systematic review and meta-analysis. Ann Surg. 2019;270(2):247–56.

    Article  PubMed  Google Scholar 

  118. Miyauchi Y, Furukawa K, Suzuki D, Yoshitomi H, Takayashiki T, Kuboki S, et al. Additional effect of perioperative, compared with preoperative, immunonutrition after pancreaticoduodenectomy: a randomized, controlled trial. Int J Surg. 2019;61:69–75.

    Article  PubMed  Google Scholar 

  119. Yang FA, Chen YC, Tiong C. Immunonutrition in patients with pancreatic cancer undergoing surgical intervention: a systematic review and meta-analysis of randomized controlled trials. Nutrients. 2020;12(9):2798.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  120. Takagi K, Umeda Y, Yoshida R, Yagi T, Fujiwara T. Systematic review on immunonutrition in partial pancreatoduodenectomy. Langenbeck's Arch Surg. 2020;405(5):585–93.

    Article  Google Scholar 

  121. Jeune F, Coriat R, Prat F, Dousset B, Vaillant JC, Gaujoux S. Pancreatic cancer surgical management. Presse Med. 2019;48(3 Pt 2):e147–e58.

    Article  PubMed  Google Scholar 

  122. Weimann A, Braga M, Carli F, Higashiguchi T, Hubner M, Klek S, et al. ESPEN guideline: clinical nutrition in surgery. Clin Nutr. 2017;36(3):623–50.

    Article  PubMed  Google Scholar 

  123. Gianotti L, Besselink MG, Sandini M, Hackert T, Conlon K, Gerritsen A, et al. Nutritional support and therapy in pancreatic surgery: a position paper of the international study group on pancreatic surgery (ISGPS). Surgery. 2018;164(5):1035–48.

    Article  PubMed  Google Scholar 

  124. Jankowski M, Las-Jankowska M, Sousak M, Zegarski W. Contemporary enteral and parenteral nutrition before surgery for gastrointestinal cancers: a literature review. World J Surg Oncol. 2018;16(1):94.

    Article  PubMed Central  PubMed  Google Scholar 

  125. Alexander DD, Bylsma LC, Elkayam L, Nguyen DL. Nutritional and health benefits of semi-elemental diets: a comprehensive summary of the literature. World J Gastrointest Pharmacol Ther. 2016;7(2):306–19.

    Article  PubMed Central  PubMed  Google Scholar 

  126. Ferrie S, Graham C, Hoyle M. Pancreatic enzyme supplementation for patients receiving enteral feeds. Nutr Clin Pract. 2011;26(3):349–51.

    Article  PubMed  Google Scholar 

  127. Sadeghi M, Keshavarz-Fathi M, Baracos V, Arends J, Mahmoudi M, Rezaei N. Cancer cachexia: diagnosis, assessment, and treatment. Crit Rev Oncol Hematol. 2018;127:91–104.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Maria Q. B. Petzel

  2. Department of Clinical Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Maria Q. B. Petzel

  3. Department of Clinical Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Chelsea S. Ebrus

  4. Department of Supportive Care Medicine, City of Hope Orange County Lennar Foundation Cancer Center, Irvine, CA, USA

    Jessica Tse Cheng

  5. Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, USA

    Nathan Parker

  6. Department of Palliative, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    An Ngo-Huang

Authors
  1. Maria Q. B. Petzel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chelsea S. Ebrus
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jessica Tse Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nathan Parker
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. An Ngo-Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to An Ngo-Huang .

Editor information

Editors and Affiliations

  1. GI Medical Oncology, The University of Texas MD Anderson Canc, Houston, TX, USA

    Shubham Pant

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Petzel, M.Q.B., Ebrus, C.S., Cheng, J.T., Parker, N., Ngo-Huang, A. (2023). Physical Activity and Nutrition Optimization in Pancreatic Cancer. In: Pant, S. (eds) Pancreatic Cancer. Springer, Cham. https://doi.org/10.1007/978-3-031-38623-7_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-38623-7_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-38622-0

  • Online ISBN: 978-3-031-38623-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation